Fed. Circ. Restricts Venue Options For Hatch-Waxman Suits
The Federal Circuit on Thursday limited where Hatch-Waxman Act patent suits over generic drugs can be filed, rejecting an argument that the suits are permitted wherever the generic product may one...To view the full article, register now.
Already a subscriber? Click here to view full article